| Value | ₹1.20 Cr |
|---|---|
| Execution period | By 31st March 2027 |
NSE filing, NSE: INFOLLION. Summary written from the filing by ALFA Finder's alert engine.
Infollion Research Services Ltd: key numbers
- Share price
- ₹132.95
- Market cap
- ₹129.1 Cr
- Revenue (annual)
- ₹100.3 Cr
- Net profit (annual)
- ₹12.72 Cr
- P/E (TTM)
- 10.2×Sector 45.2×
- Promoter holding
- 51.66%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Infollion Research Services Ltd
All →Infollion Research Services Earnings Call Transcript: Key Takeaways
Infollion reported its strongest half-year performance with revenue reaching ₹60 Cr, driven by international expansion and new verticals like HUKSA. Management is focused on gaining market share through aggressive pricing and AI-related expert use cases.
Infollion Research Services Investor Presentation: Key Takeaways
Infollion reported strong H1 FY27 results with ₹59.04 Cr revenue, up 15.6% YoY. Strategy focuses on AI integration, geographic expansion in US/MENA, and corporate L&D via Huksa.
Infollion Research Services H1 FY27 Results: Net Profit ₹6.7 Cr, Down 8.2% YoY
Infollion Research Services Ltd reported revenue from operations of ₹59 Cr (+15.5% YoY) and net profit of ₹6.7 Cr (-8.2% YoY) for H1 FY27.
- Key figure
- Net profit ₹6.7 Cr · -8.2% YoY
Infollion Research Services Other Announcement
Infollion Research Services Limited updated its list of authorized personnel for determining materiality under Regulation 30(5). The list includes the Managing Director, CFO, and Company Secretary.
Infollion Research Services Annual General Meeting
Infollion Research Services Limited held its 17th Annual General Meeting on September 17, 2026. Shareholders considered financial statements, director reappointment, and revised remuneration for the MD.
Infollion Research Services Annual General Meeting
Infollion Research Services Limited has issued a notice for its 17th Annual General Meeting scheduled for September 17, 2026, to consider financial statements and director-related matters.
Other acquisition announcements
All →Krishna Institute of Medical Sciences Acquisition Worth ₹15 Cr
KIMS acquired a 5.82% stake in Ushahkal Abhinav Specialty Hospital LLP for Rs.15 Crore via primary infusion. The Sangli hospital reported FY26 turnover of Rs.80.42 Crore.
- Value
- ₹15.00 Cr
Krishna Institute of Medical Sciences Acquisition Worth ₹79.5 Cr
KIMS Ltd acquired a 51% stake in Sarvottam Health Care Private Limited for up to ₹79.50 Crore, aiming to expand its healthcare operations in Kakinada.
- Value
- ₹79.50 Cr
Meesho Acquisition Worth ₹50 Cr
Meesho approved up to Rs.50 Crore further investment in Retail Pulse Labs, payable in tranches. It follows the Kirana Club acquisition, making RPLPL a step-down subsidiary.
- Value
- ₹50.00 Cr
- Execution
- Within 1 year from the closing of the first tranche of the original acquisition
Meesho Acquisition Worth ₹18.74 Cr
Meesho will acquire a further stake in Retail Pulse Labs for ₹18.74 Crore cash. The step-down deal depends on completing the first Kirana Club tranche.
- Value
- ₹18.74 Cr
Meesho Acquisition Worth ₹6.17 Cr
Meesho will acquire 100% of Singapore-based Kirana Club in cash, up to USD 6.5 lakh in tranches. The target runs a digital platform for grocery retailers.
- Value
- ₹6.17 Cr
Skyways Air Services Acquisition Worth ₹3.13 Cr
Skyways Air Services will invest Rs.3.13 Crore in cash for additional equity in UAE subsidiary Skyways SLS Cargo Services LLC. The investment funds working capital needs.
- Value
- ₹3.13 Cr
- Execution
- Indicative completion within 30 days